DE69618579D1 - Rekombinante dna-vektoren für die gentherapie - Google Patents

Rekombinante dna-vektoren für die gentherapie

Info

Publication number
DE69618579D1
DE69618579D1 DE69618579T DE69618579T DE69618579D1 DE 69618579 D1 DE69618579 D1 DE 69618579D1 DE 69618579 T DE69618579 T DE 69618579T DE 69618579 T DE69618579 T DE 69618579T DE 69618579 D1 DE69618579 D1 DE 69618579D1
Authority
DE
Germany
Prior art keywords
gene therapy
recombinant dna
dna vectors
novel
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69618579T
Other languages
English (en)
Other versions
DE69618579T2 (de
Inventor
H Guenzburg
Brian Salmons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
AUSTRIAN NORDIC BIOTHERAPEUTIC
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AUSTRIAN NORDIC BIOTHERAPEUTIC, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical AUSTRIAN NORDIC BIOTHERAPEUTIC
Application granted granted Critical
Publication of DE69618579D1 publication Critical patent/DE69618579D1/de
Publication of DE69618579T2 publication Critical patent/DE69618579T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69618579T 1995-03-09 1996-03-08 Rekombinante dna-vektoren für die gentherapie Expired - Fee Related DE69618579T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK24495 1995-03-09
PCT/EP1996/001002 WO1996028564A1 (en) 1995-03-09 1996-03-08 Novel recombinant dna vectors for gene therapy

Publications (2)

Publication Number Publication Date
DE69618579D1 true DE69618579D1 (de) 2002-02-21
DE69618579T2 DE69618579T2 (de) 2002-10-02

Family

ID=8091367

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69618579T Expired - Fee Related DE69618579T2 (de) 1995-03-09 1996-03-08 Rekombinante dna-vektoren für die gentherapie

Country Status (9)

Country Link
US (1) US6730511B1 (de)
EP (2) EP0817859B1 (de)
JP (1) JPH11508441A (de)
AT (1) ATE212061T1 (de)
AU (1) AU5104096A (de)
DE (1) DE69618579T2 (de)
DK (1) DK0817859T3 (de)
ES (1) ES2171657T3 (de)
WO (1) WO1996028564A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688590B2 (en) * 1994-09-02 1998-03-12 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
EP0817858B1 (de) 1995-03-09 2003-04-23 Austrian Nordic Biotherapeutics AG Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
DE102009024862A1 (de) 2009-06-09 2010-12-16 Uwe Michael Schlitt Dosiervorrichtung für flüssige Medien

Also Published As

Publication number Publication date
WO1996028564A1 (en) 1996-09-19
US6730511B1 (en) 2004-05-04
ATE212061T1 (de) 2002-02-15
DE69618579T2 (de) 2002-10-02
EP1162273A1 (de) 2001-12-12
AU5104096A (en) 1996-10-02
ES2171657T3 (es) 2002-09-16
EP0817859B1 (de) 2002-01-16
JPH11508441A (ja) 1999-07-27
EP0817859A1 (de) 1998-01-14
DK0817859T3 (da) 2002-04-29

Similar Documents

Publication Publication Date Title
ATE213743T1 (de) Typ-ii-interleukin-1-rezeptoren
NL300008I2 (nl) Tumornecrosis factor-alfa en -bet-receptors.
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
DE69936784D1 (de) Behandlung von gebärmutterhalskrebs
SE8106641L (sv) Hybrida humanleukocytinterferoner
ATE298789T1 (de) Negativstrand rna virus mit selbständiger replikationsaktivität
ATE549347T1 (de) Gene von säugetiere, und damit verbundene reagentien, methoden
HUP9801608A2 (hu) A 11. típusú humán papillomavírusból származó L1-fehérjét kódoló szintetikus HPV6/11-L1-hibrid-DNS
ATE315087T1 (de) Neuartige auf p53 ansprechende gene
NL300271I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
DK1015477T3 (da) 32 humane sekreterede proteiner
DE3851035D1 (de) Interleukin-7.
MX9203645A (es) Nuevos interferones de humano y proceso biotecnologico para su produccion.
DE69618579D1 (de) Rekombinante dna-vektoren für die gentherapie
ATE386130T1 (de) Adenovirale vektoren für die gentherapie
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
FR2744455B1 (fr) Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
NO975286L (no) Promotere for genekspresjon
ATE455858T1 (de) Konditionell replizierende virale vektoren und ihre verwendung
ATE302214T1 (de) Enamel-matrix bezogene polypeptide
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
ATE122723T1 (de) Retinoblastoma-genprodukt-antikörper und deren verwendungen.
WO2003052377A9 (en) 41 human secreted proteins
DE602004024314D1 (de) Koexpressionsvektor für die membrandomänen von virushüllproteinen und verwendungen davon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GSF - FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT

8339 Ceased/non-payment of the annual fee